Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Novo Nordisk

Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
Jul 4, 2026, 10:56 | Voices
Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
Alec Van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared a…
Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
Jun 28, 2026, 19:05 | Voices
Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
Jack Shuang Hou, Diagnostic Executive, Microfluidics and Immunoassay Specialist, shared a post on LinkedIn: "Novo…
Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
Jun 15, 2026, 10:07 | Voices
Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
Habib Bennaceur, Senior Vice President, Rare Disease at Novo Nordisk, shared a post on LinkedIn:…
Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
Jun 1, 2026, 17:12 | Voices
Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
Marie-Claire Kofi, Chief Executive Officer at Plasma of Hope, shared a post on LinkedIn: "As…
Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
May 30, 2026, 18:09 | Voices
Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:…
Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
May 24, 2026, 04:57 | Voices
Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
Ahmed Elsobky, Chairman of the Board of Directors at Egypt Healthcare Authority, shared on LinkedIn:…
Abdelaziz Fahem։ Novo Nordisk Reports Positive Phase 3 Results for Etavopivat
Apr 21, 2026, 16:03 | Voices
Abdelaziz Fahem։ Novo Nordisk Reports Positive Phase 3 Results for Etavopivat
Abdelaziz Fahem, Vice President of Medical Affairs and Clinical Research at Hemara Bio, shared a…
Can Lived Experiences Shape Future Advances in Haemophilia Care? - Novo Nordisk
Apr 21, 2026, 15:06 | Voices
Can Lived Experiences Shape Future Advances in Haemophilia Care? - Novo Nordisk
Novo Nordisk shared a post on LinkedIn: "Can lived experiences shape future advances in haemophilia…
Rucha Patil: Delighted to Contribute to The Round Table on Integrated Care of Hemophilia and Hemoglobinopathies
Feb 16, 2026, 13:25 | Voices
Rucha Patil: Delighted to Contribute to The Round Table on Integrated Care of Hemophilia and Hemoglobinopathies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared…
Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jan 24, 2026, 15:15 | Voices
Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn: ''We’re…
Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
Jan 17, 2026, 04:59 | Science
Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of…
Danielle Gilliam on FDA's Approval of Wegovy Pill from Novo Nordisk
Dec 24, 2025, 05:17 | Insight
Danielle Gilliam on FDA's Approval of Wegovy Pill from Novo Nordisk
Danielle Gilliam, Executive Medical Science Liaison Cardiovascular and Renal at Novo Nordisk North America, shared…
Colleen Silk on Novo Nordisk Performance at ASH25
Dec 14, 2025, 15:07 | Voices
Colleen Silk on Novo Nordisk Performance at ASH25
Colleen Silk, Corporate Vice President, Rare Disease at Novo Nordisk, shared on LinkedIn: ''I’m so…
Sara Motka: We Create Greater Synergies Between Haemophilia and Haemoglobinopathies
Dec 7, 2025, 05:41 | Organizations
Sara Motka: We Create Greater Synergies Between Haemophilia and Haemoglobinopathies
Sara Motka, Head of Programmes at the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, reposted from…
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Dec 5, 2025, 06:04 | Organizations
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared on…
Habib Bennaceur: Novo Nordisk Completed its Acquisition of Zaltenibart from Omeros Corporation
Dec 2, 2025, 11:22 | Drugs
Habib Bennaceur: Novo Nordisk Completed its Acquisition of Zaltenibart from Omeros Corporation
Habib Bennaceur, SVP Rare Disease Unit at Novo Nordisk, shared on LinkedIn: ''I am pleased…
Jack Shuang Hou Shares Major Neurology Updates This Week
Nov 29, 2025, 17:23 | Insight
Jack Shuang Hou Shares Major Neurology Updates This Week
Jack Shuang Hou, Scientific Director at Jtests, shared on LinkedIn: ''FDA Approves Intrathecal Zolgensma, Ozempic…
Melissa Leichter: My Team Used AI to Pinpoint Likely Undiagnosed Patients with Glanzmann’s Thrombasthenia
Nov 22, 2025, 16:05 | Insight
Melissa Leichter: My Team Used AI to Pinpoint Likely Undiagnosed Patients with Glanzmann’s Thrombasthenia
Melissa Leichter, Rare Disease Executive at Novo Nordisk, shared on LinkedIn: ''I've had a number…
Michael Makris: Novo Nordisk has Decided to Discontinue Their Haemophilia A Gene Editing Program
Nov 19, 2025, 02:49 | Voices
Michael Makris: Novo Nordisk has Decided to Discontinue Their Haemophilia A Gene Editing Program
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, Editor-in-Chief of…
Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
Nov 15, 2025, 15:45 | Science
Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on…
Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
Nov 4, 2025, 08:22 | Voices
Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
Colleen Silk, Corporate Vice President, Rare Disease at Novo Nordisk, shared on LinkedIn: ''Rare diseases…
Novo Nordisk Submits Biologics License Application for Mim8 (Denecimig) in Hemophilia A
Oct 31, 2025, 14:21 | Drugs
Novo Nordisk Submits Biologics License Application for Mim8 (Denecimig) in Hemophilia A
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn: ''Novo Nordisk has submitted a Biologics License…
Jason C. Foster: The Industry Isn’t Abandoning Cell Therapy, It is Returning to What Works
Oct 23, 2025, 10:01 | Voices
Jason C. Foster: The Industry Isn’t Abandoning Cell Therapy, It is Returning to What Works
Jason C. Foster, Chief Executive Officer and Executive Director at Ori Biotech, shared a post on…
Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Oct 4, 2025, 10:10 | Science
Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Alessio Branchini, Associate Professor of Molecular Biology at University of Ferrara, shared on LinkedIn: ''Very…
Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
Oct 2, 2025, 10:48 | Insight
Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
  Kanishk Kumar, Digital Marketing Executive at DelveInsight Business Research LLP, posted on LinkedIn: ''Tissue…
Hemophilia Care is Entering a New Era
Oct 2, 2025, 07:37 | Organizations
Hemophilia Care is Entering a New Era
Hemophilia Federation (India) shared a post on LinkedIn: ”Hemophilia care is entering a new era!…
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Sep 15, 2025, 08:26 | Organizations
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Hemophilia Federation of America (HFA) has shared a post on LinkedIn: “Join Novo Nordisk and…
Hemophilia Care Advances: Learn About Prefilled Injection Pen Treatment with HFA
Sep 5, 2025, 05:22 | Organizations
Hemophilia Care Advances: Learn About Prefilled Injection Pen Treatment with HFA
Hemophilia Federation of America (HFA), shared a post on X: “New option for hemophilia care?…
Melissa Leichter Announces The Newly FDA Approved Subcutaneous Prophylactic Treatment for Hemophilia A or B
Aug 1, 2025, 17:31 | Insight
Melissa Leichter Announces The Newly FDA Approved Subcutaneous Prophylactic Treatment for Hemophilia A or B
Melissa Leichter, Rare Disease Executive, Novo Nordisk, shared a proud announcement post on LinkedIn: ''Today…
Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Jul 28, 2025, 13:18 | Organizations
Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Hemophilia Federation of America (HFA) shared a reminder post on X: ''Time is running out…
Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
Jul 23, 2025, 15:34 | Voices
Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
Hemophilia Federation of America (HFA) shared a post on X: “Living with Hemophilia B: From…
1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Jul 19, 2025, 17:52 | Organizations
1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Thalassaemia International Federation (TIF) shared a grateful post on LinkedIn: ''What an unforgettable journey in…
Jessica Garcia: 2025 HTRS/Novo Nordisk Clinical Scholar Award Recipient
Jun 27, 2025, 16:36 | Insight
Jessica Garcia: 2025 HTRS/Novo Nordisk Clinical Scholar Award Recipient
Hemostasis and Thrombosis Research Society recently shared a congratulating post on X. “Congratulations to Jessica…
At ISTH 2025, Novo Nordisk Will Share Phase 3 Hemophilia Study Results
Jun 11, 2025, 07:38 | Insight
At ISTH 2025, Novo Nordisk Will Share Phase 3 Hemophilia Study Results
Novo Nordisk US shared on X: “Novo Nordisk is presenting our latest hemophilia research data,…
All: 34 Posts: 1 - 100
NewsFeed